Oncovista Innovative Therapies Inc
OTC:OVIT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Oncovista Innovative Therapies Inc
OTC:OVIT
|
US |
|
F
|
Fujimi Inc
TSE:5384
|
JP |
|
V
|
Vail Resorts Inc
F:VAI
|
US |
|
Alligator Energy Ltd
ASX:AGE
|
AU |
|
I
|
Isracann Biosciences Inc
OTC:ISCNF
|
CA |
|
H
|
Haffner Energy SA
PAR:ALHAF
|
FR |
|
N
|
Nissan Chemical Corp
XMUN:NSC
|
JP |
|
L
|
Legence Corp
NASDAQ:LGN
|
US |
|
Imperial Petroleum Inc
NASDAQ:IMPP
|
GR |
|
Rheinmetall AG
OTC:RNMBF
|
DE |
|
TomCo Energy PLC
F:NI41
|
UK |
|
Oregon Pacific Bancorp
OTC:ORPB
|
US |
Bankruptcy Probability
Oncovista Innovative Therapies Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Oncovista Innovative Therapies Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
O
|
Oncovista Innovative Therapies Inc
OTC:OVIT
|
2.4k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
470.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
188.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Oncovista Innovative Therapies Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Oncovista Innovative Therapies Inc has total debt of 1.2m USD. This includes both short-term (450k USD) and long-term (700k USD) debt.
You can find a full breakdown on its Balance Sheet.